MariMed, Inc (CSE: MRMD) (OTCQX: MRMD) announced its financial results late Monday for the first quarter ended March 31, 2023.

“I am pleased to report another solid quarter,” said CEO Jon Levine. “We reported our 13th consecutive quarter of positive adjusted EBITDA, and we expect to generate our fourth consecutive year of positive operating cash flow. MariMed is one of the only companies in the cannabis industry to report positive cash flows and positive EBITDA over this extended period of time.”

During the first quarter, the Company announced the following developments in the implementation of its strategic growth plan:

Full story available on Benzinga.com

A note to our visitors

This website has updated its privacy policy in compliance with changes to European Union data protection law, for all members globally. We’ve also updated our Privacy Policy to give you more information about your rights and responsibilities with respect to your privacy and personal information. Please read this to review the updates about which cookies we use and what information we collect on our site. By continuing to use this site, you are agreeing to our updated privacy policy.